Objective
The development of a highly innovative method for antibody design (phage antibody libraries), has been pioneered by research groups in USA and a few European countries. The objective of this project is the exploitation of unique know-how provided by a research group at the German Cancer Research Centre through an alliance with two companies in Norway, one well established SME providing novel technology relating to solid surface separations (Dynal) and one recently established NTBF to introduce the technology to Norway
Funding Scheme
CSC - Cost-sharing contractsCoordinator
AFFITECH AS
Address
Oslo Research Park - Gaustadallen 21
0371 Oslo
Norway
0371 Oslo
Norway
Participants (3)
CENTRAL LABORATORY NORWEGIAN RADIUM HOSPITAL
Norway
DEUTSCHES KREBSFOSCHUNGSZENTRUM
Germany
DYNAL
Norway